Sheffield Teaching Hospitals NHS Foundation Trust
284
29
38
192
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
5.6%
16 terminated/withdrawn out of 284 trials
92.3%
+5.8% vs industry average
8%
23 trials in Phase 3/4
5%
10 of 192 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (284)
Differences in Preparation for Small Bowel Capsule Endoscopy
Role: lead
Traditional Dietary Advice Versus Low FODMAP Diet in Postprandial Functional Dyspepsia
Role: lead
Impact of Isolation in Patients With IBD During the COVID-19 Crisis
Role: lead
Characterisation of Cortical Vestibular Evoked Potentials (C-VEPs)
Role: lead
MAGNIFY - Pulmonary Magnetic Resonance Imaging for Cystic Fibrosis
Role: lead
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
Role: lead
Assessing Changes in Gadoxetate Metabolism by the Liver Using MRI
Role: lead
Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma (VAPOR2)
Role: collaborator
Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma
Role: collaborator
Investigating the Tolerability and Feasibility of tVNS Following aSAH
Role: lead
The Use of Advanced Imaging in HFpEF
Role: lead
Virtual Dietetic Interventions in Patients With Coeliac
Role: lead
Development of Novel Physiological CMR Methods in Health and Disease
Role: lead
SpaceOAR Post-Market Registry Study
Role: lead
Efficacy of Symprove Probiotics in Coeliac Disease
Role: lead
WILL lOWer Dose Aspirin be Better With Rivaroxaban in Patients With Chronic Coronary Syndromes?
Role: lead
Improving Pulmonary Hypertension Screening by Echocardiography
Role: collaborator
Better Outcomes Through Optimal Sleep in Surgical Training
Role: lead
MND Together: Phase 1
Role: collaborator
NIV Mask and Headgear Evaluation
Role: collaborator